Stocks
China Biologic Products Holdings (CBPO) EBITDA margin US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 41.9% | 39.3% | 36.3% | 38.5% | 41.1% | 41.1% | ||
| Changes by years, y/y, % | +1pp | -3pp | -3pp | +2pp | +3pp | +0.2% | |||
China Biologic Products Holdings. EBITDA margin, %
China Biologic Products Holdings. EBITDA margin, changes, pp
China Biologic Products Holdings (CBPO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2019Q4 | 2020Q1 | 2020Q2 | 2020Q3 | 2020Q4 | LTM ? | |||
| EBITDA margin, % | ? | 23.8% | 44.1% | 44.0% | 40.5% | 34.5% | 41.1% | |
| Changes by years, y/y, % | -18pp | +4pp | +3pp | -4pp | +11pp | |||
| Changes by quarters, q/q, % | -21pp | +20pp | 0pp | -4pp | -6pp | |||
